Rare Variants in the DNA Repair Pathway and the Risk of Colorectal Cancer-Reference-Cited by-同舟云学术

Rare Variants in the DNA Repair Pathway and the Risk of Colorectal Cancer

Published:2021-02-24 Issue:5 Volume:30 Page:895-903
ISSN:1055-9965
Container-title:Cancer Epidemiology Biomarkers & Prevention
language:en
Short-container-title:Cancer Epidemiol Biomarkers Prev

Author:

Matejcic Marco^ORCID,Shaban Hiba A.,Quintana Melanie W.^ORCID,Schumacher Fredrick R.,Edlund Christopher K.,Naghi Leah,Pai Rish K.^ORCID,Haile Robert W.^ORCID,Levine A. Joan,Buchanan Daniel D.^ORCID,Jenkins Mark A.,Figueiredo Jane C.,Rennert Gad^ORCID,Gruber Stephen B.^ORCID,Li Li,Casey Graham,Conti David V.,Schmit Stephanie L.^ORCID

Funder

NCI

NIH

Damon Runyon Cancer Research Foundation Clinical Investigator Award

Case Center for Transdisciplinary Research on Energetics and Cancer

National Human Genome Research Institute

National Institute of Environmental Health Sciences

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Production of novel theranostic nano-vector based on superparamagnetic iron oxide nanoparticles/miR-497 targeting colorectal cancer;2024-08-30

2. High-throughput screening of the Saccharomyces cerevisiae genome for 2-amino-3-methylimidazo [4,5-f] quinoline resistance identifies colon cancer-associated genes;G3: Genes, Genomes, Genetics;2023-09-22

3. High-Throughput Screening of theSaccharomyces cerevisiaeGenome for 2-Amino-3-Methylimidazo [4,5-f] Quinoline Resistance Identifies Colon Cancer-Associated Genes;2022-10-27

4. Identification of ERCC8 as a novel cisplatin-resistant gene in esophageal cancer based on genome-scale CRISPR/Cas9 screening;Biochemical and Biophysical Research Communications;2022-02